Midatech Pharma US, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients
Phase 4
Terminated
- Conditions
- Oral Mucositis
- Interventions
- Device: GelclairCombination Product: First® Mouthwash BLM
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Midatech Pharma US Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT03490396
- Locations
- 🇺🇸
Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath